The FYVE domain is an approx. 80 amino acid motif that binds to the phosphoinositide PtdIns3P with high specifi city and affi nity. It is present in 38 predicted gene products within the human genome, but only in 12-13 in Caenorhabditis elegans and Drosophila melanogaster. Eight of these are highly conserved in all three organisms, and they include proteins that have not been characterized in any species. One of these, WDFY2, appears to play an important role in early endocytosis and was revealed in a RNAi (RNA interference) screen in C. elegans. Interestingly, some proteins contain FYVE-like domains in C. elegans and D. melanogaster, but have lost this domain during evolution. One of these is the homologue of Rabatin-5, a protein that, in mammalian cells, binds both Rab5 and Rabex-5, a guanine-nucleotide exchange factor for Rab5. Thus the Rabatin-5 homologue suggests that mechanisms to link PtdIns3P and Rab5 activation developed in evolution. In mammalian cells, these mechanisms are apparent in the existence of proteins that bind PtdIns3P and Rab GTPases, such as EEA1, Rabenosyn-5 and Rabip4´. Despite the comparable ability to bind to PtdIns3P in vitro, FYVE domains display widely variable abilities to interact with endosomes in intact cells. This variation is due to three distinct properties of FYVE domains conferred by residues that are not involved in PtdIns3P head group recognition: These properties are: (i) the propensity to oligomerize, (ii) the ability to insert into the membrane bilayer, and (iii) differing electrostatic interactions with the bilayer surface. The different binding properties are likely to regulate the extent and duration of the interaction of specifi c FYVE domain-containing proteins with early endosomes, and thereby their biological function. 
Introduction
Numerous aspects of mammalian physiology are determined by sorting mechanisms in the endocytic pathway. Sorting patterns of just a few molecules in specifi c cell types can have profound effects on the physiology of the whole organism. A good example is the pathological alteration of carbohydrate homoeostasis upon disruption of normal sorting of the glucose transporter GLUT4. This transporter is expressed only in adipocytes and muscle cells, and is present on the plasma membrane and diverse sub-compartments of the early endocytic pathway [1, 2] . The distribution of GLUT4 among these compartments responds to the metabolic state of the organism, increasing on the plasma membrane in response to, for example, insulin or exercise. Abnormalities in GLUT4 traffi cking are hallmarks of the state of insulin resistance that underlies Type II diabetes [3, 4] . Another example is that of the EGFR (epidermal growth factor receptor), which is expressed in epithelial cells and undergoes rapid internalization and intracellular degradation upon ligand binding [5, 6] . Changes in the levels of EGFR, which can occur upon disruption of normal degradative mechanisms, are seen in many types of cancers [7, 8] . GLUT4 and the EGFR also represent two examples of molecules that have clearly different fates following internalization, the former recycling to the plasma membrane and the latter becoming degraded. The cellular and molecular mechanisms by which these proteins are sorted are not fully understood, but involve the synthesis and turnover of specifi c phosphoinositides at the membrane-cytosol interface.
PtdIns3P in the control of endosome sorting
Phosphoinositides have been found to infl uence traffi cking both in the secretory and endocytic pathways in an evolutionarily conserved manner. The role of phosphoinositides in endocytic traffi cking was genetically proven by the discovery that a gene required for vacuolar protein sorting in yeast, vps34, had homology to the mammalian p110 catalytic subunit of PI3K (phosphoinositide 3-kinase) [9] . Subsequent studies demonstrated that vps34 catalysed the synthesis of PtdIns3P, and that mammalian cells contain a homologous, vps34-like, PI3K [10] . Insights into the mechanism whereby PtdIns3P might infl uence protein traffi cking came with the discovery of proteins that interacted specifi cally and with high avidity with this lipid. The fi rst of these to be discovered was the protein EEA1, which was found to be released from endosomal membranes in response to inhibition of PI3K activity with wortmannin, and to bind in vitro to liposomes containing PtdIns3P [11] . EEA1 had been identifi ed as the antigen recognized by serum from a group of patients with an autoimmune disease [12] , and localized to endosomes in mammalian cells [13] . The binding of EEA1 to endosomes had been shown to require the FYVE domain, an approx. 80 amino acid double zinc fi nger localized at the extreme C-terminus of EEA1 [13] . The FYVE domain was then found to directly mediate the binding of EEA1 to PtdIns3P [14] [15] [16] . Thus one of the mechanisms by which phosphoinositides infl uence traffi cking is by enabling the assembly of proteins and protein complexes at the membrane-cytoplasmic interface. An example of a multiprotein complex that involves the FYVE domain interactions with PtdIns3P is ESCRT, a complex of twelve proteins that form four multiprotein assemblies called ESCRT 0, I, II and III [17] [18] [19] [20] [21] . Mammalian homologues of these proteins include the ESCRT 0 and I homologues Hrs, TSG101, hVps28, and hVps37. Hrs binds to PtdIns3P-enriched endosomes via its FYVE domain, and plays a key role in the recruitment of additional ESCRT complexes onto the endosomal membrane [22] [23] [24] 25] . Hrs, and other elements of the ESCRT complex, can bind ubiquitin-modifi ed cargo proteins, such as the activated EGFR [26, 27] , and interference studies indicate a role for some of them in degradation of lysosome-directed cargo [27] . Together with Fab1/PikFYVE, which is involved in the control of multivesicular body formation [28] [29] [30] [31] , Hrs can regulate traffi cking towards the degradative arm of the early endocytic pathway. FYVE domain-containing proteins also appear to function in the recycling arm of the endocytic pathway. For example, when expressed at high levels, the proteins Rabenosyn5 and Rabip4 enhance transferrin and GLUT4 recycling, respectively, and depletion of Rabenosyn5 by RNA interference impairs transferrin recycling [32] [33] [34] .
FYVE domain-containing proteins are also linked to signal transduction. Hrs is rapidly tyrosine phosphorylated in response to polypeptide growth factors such as EGF (epidermal growth factor) and HGF (hepatocyte growth factor) [35, 36] , and EEA1 (early endosomal autoantigen 1) has been reported to be phosphorylated by p38 MAPK (mitogen-activated protein kinase) [37] , although the functional effects of these phosphorylation events are not fully understood. Evidence for a direct involvement of a FYVE domain-containing protein in signal transduction has come from the discovery of the protein SARA (smad anchor for receptor activation). SARA is a 135 kDa polypeptide that contains binding domains for both Smad2 and the TGF-β (transforming growth factor β) receptor [38] . The endosomal localization of the activated TGF-β receptor, Smad2 and SARA is necessary for nuclear translocation of Smad2 and for the activation of Smad-specifi c transcription [39] [40] [41] [42] .
Evolutionary conservation of FYVE domain-containing proteins
The human genome contains 38 genes predicted to encode proteins with FYVE domains, the functions of most of which are unknown. One approach to elucidate the conserved biological functions of these FYVE domain-containing proteins is to study them in simpler organisms. Caenorhabditis elegans and Drosophila melanogaster contain only 12-13 genes encoding proteins with recognizable FYVE domains containing some or all of the structural features necessary to bind PtdIns3P. All of these have homologues in the human genome (Table 1) , and nine are expressed in all three organisms. Cladograms of these FYVE domains reveal that eight are highly conserved and are probably orthologues (Figure 1 ). The FYVE domains of these eight groups of proteins contain all the structural features required for PtdIns3P recognition (Figure 2 ). The least conserved within these three species is Rabenosyn-5, which, despite high conservation of residues involved in PtdIns3P binding, contains large, non-conserved inserted sequences within different regions of the FYVE domain. Other FYVE-domain containing proteins are conserved among two of these three species; for example, the prototypical FYVE domain-containing protein EEA1 does not appear to have a homologue in D. melanogaster. Interestingly, C. elegans and D. melanogaster both have FYVE-like domain-containing proteins that lack the motif in humans (Figure 3) . One of these is Rabaptin-5, a protein characterized in mammalian cells and found to exist in a complex with Rabex-5, a guanine-nucleotide exchange factor for Rab5 [43] . Although it is unclear whether the FYVE domains of the C. elegans or D. melanogaster homologues of Rabatin-5 actually bind to PtdIns3P, it is interesting to speculate on the possibility that the activation of Rab5 in C. elegans or D. melanogaster may be linked to endosomal function through the interactions between Rabex-5, Rabaptin-5, and PtdIns3P enriched endosomes. Demonstrated links between Rab5 activity and PtdIns3P levels exist in mammalian cells, in the form of proteins that can interact simultaneously with both Rab5 and PtdIns3P. These include EEA1, which contains two binding sites for activated Rab5, one at the N-terminus and one in the vicinity of the FYVE domain [44] [45] [46] . Rabenosyn5 and Rabip4´ also interact with Rab5, as well as with Rab4 [32, 47] . Precisely how the dual interaction of these proteins with PtdIns3P and Rab GTPases regulates sorting or traffi cking is not yet clear. The analysis of protein function in C. elegans is facilitated by the availability of many backgrounds and readouts that can be used to monitor specifi c pathways. For example, endocytosis can be monitored indirectly or directly by looking for an Unc (uncoordinated) phenotype indicative of defi cient synaptic vesicle recycling [48, 49] ; by accumulation of yolk in the pseudocoelom due to decreased endocytosis in eggs [50] , or by the lack of rhodamine-dextran endocytosis by intestinal cells of the gut [51] . Resistance of aldicarb treatment in hypersensitive strains has also been used to identify genes involved in endocytosis or exocytosis at the neuromuscular synapse [52] . In a system developed by Fares and Greenwald [51], endocytosis is monitored through the uptake of GFP (green fl uorescent protein), secreted from muscle cells lining the gut, into coelomocytes. When Vps34, dynamin, RME-1 and other proteins involved in endocytosis are targeted by injection of dsRNA (double-stranded RNA), GFP accumulates in the pseudocoelom and fails to accumulate in coelomocytes [51] . Using the same strategy, we targeted 12 FYVE domain-containing proteins to determine their role in endocytosis. The largest accumulation of GFP in the worm pseudocoelom was found upon the silencing of the protein WDFY2 by injection of its respective dsRNAs (Figure 4) . Further experiments, including gene knockouts and more quantitative microscopy, are required to rule out more subtle effects of the remaining proteins in this background. In addition, effects on cellular functions other than endocytic traffi c are likely to be more evident in other background strains. Nevertheless, these results reveal WDFY2, one of the highly conserved FYVE domain-containing proteins, as an important element in the endocytic pathway.
Regulatory structural features of the FYVE domain
The presence of a canonical FYVE domain in any protein implies that it can interact with PtdIns3P, and therefore could bind to early endosomes in intact cells. Indeed, many FYVE domain-containing proteins are localized in this manner. Paradoxically, when expressed in cells, most isolated FYVE domains (i.e. amino acid sequences starting 1-15 residues from the fi rst conserved tryptophan residue and extending approx. 5 residues from the last conserved cysteine residue) do not associate with endosomes, but rather remain cytosolic. To determine the basis for this inconsistency, we analysed the endosome binding properties of fi ve different FYVE domains derived from the proteins EEA1, SARA, Hrs, Frabin and FGD1 [53] . Based on NMR and crystallographic analyses [54] [55] [56] , FYVE domains are predicted to be comprised of four short β-strands and a C-terminal α-helix assembled around two Zn 2+ ions, which coordinate the thiol groups of cysteine residues from the four conserved CXXC motifs. Six residues directly contact the Ins(1,3)P 2 group. These residues are localized within three conserved signature motifs, the WXXD, R(R/K)HHCR, and RVC motifs ( Figure 5 ).
While the FYVE domains of SARA, Hrs, Frabin and EEA1 contain all these features, only the SARA FYVE domain localized to endosomes when expressed as a GFP-fusion protein, despite the fact that, in vitro, its affi nity for PtdIns3P was indistinguishable from that of EEA1. The FYVE domain of EEA1 itself remained cytoplasmic even when expressed at very high levels ( Figure 6 , left panels in each pair). An additional difference between the FYVE domains of EEA1 and SARA was that, in vitro, the purifi ed FYVE domain of SARA was eluted from sizing columns as a stable dimer, whereas the EEA1 domain was monomeric [53] . To defi ne the role of oligomerization in in vivo binding to endosomes, we performed experiments in which we enforced dimerization of different FYVE domains using a cell permeant chemical dimerizer. The propensity to form dimers indeed contributed greatly to the ability of FYVE domains to localize to endosomes ( Figure 6 , right panels in each pair), and residues in the region corresponding to the dimer interface in the EEA1 C-terminus crystal structure were found to strongly infl uence the ability of FYVE domains to localize to endosomes [53] . FRET (fl uorescence resonance energy transfer) studies of the full-length Hrs molecule suggested that indeed it exists in a multimeric state in cells [53] , a prediction recently confi rmed by the fi nding that Hrs forms hexameric structures on the endosomal surface [57] .
In addition to multivalency, endosome binding is infl uenced by regions of the FYVE domains that contribute to membrane insertion [58] [59] [60] . The degree of membrane insertion of FYVE domains is dependent on a cluster of residues close to the PtdIns3P binding pocket ( Figure 5 ) termed the 'turret loop' [55, 61] . Mutations in turret loop amino acids also lead to signifi cant alterations in endosome binding propensities of FYVE domains; for example, a single substitution in the turret loop of SARA with the corresponding amino acid from the turret loop of EEA1 (a substitution of a phenylalanine residue to a valine residue) resulted in a marked decrease in endosomal binding [53] , while the substitution in the turret loop of Hrs with the corresponding amino acid from SARA (substitution of an asparagine residue for a lysine residue) resulted in a marked increase in membrane penetration and endosomal binding [62] . It has been proposed that the binding of PtdIns3P is necessary to unmask the hydrophobicity of the turret loop residues, acting like an electrostatic switch to produce membrane penetration [59] .
Electrostatic interactions are also involved in determining the interaction of FYVE domains with bilayers, and computer modelling has suggested they may defi ne the angle at which the FYVE domain docks onto the membrane [58, 63] . Experiments where chimaeras were created between full-length proteins and FYVE domains with different predicted docking angles could provide very interesting information on the physiological signifi cance of these different membrane-binding modes. An additional regulatory mechanism that has been recently proposed involves the pH sensitivity of the conserved histidine residues within the RRHHCR motif in the FYVE domain of EEA1 [64] . Protonation of these histidine residues at low pH correlated with enhanced bilayer binding. These results suggest the hypothesis that the function of proteins containing FYVE domains may be regulated by changes in cellular cytoplasmic pH. Future experiments in which the functions of full-length FYVE domain-containing proteins are probed under conditions of varying cytoplasmic pH will be necessary to test this interesting hypothesis.
In summary, the FYVE domain-containing protein family plays multiple roles in the early endocytic pathway, infl uencing early endocytosis, recycling and degradation. The dual interaction of some FYVE domain-containing proteins with small Rab GTPases may be crucial in defi ning sorting events that take place within early endosomes. Structural differences between FYVE domains may play an important regulatory role by determining the extent and timing of protein interactions on the surface of early endosomes. Figure 6 Binding of FYVE domains to endosomal membranes is enhanced by oligomerization. FYVE domains shown in the top panel were generated as N-terminal fusions with enhanced GFP and the dimerizable moiety Fv. HeLa cells expressing the FYVE domain construct of the protein indicated on the left of each pair of panels were imaged before and after treatment with the cell permeant dimerizer AP20187 for 10 min. Before dimerization, all but the SARA FYVE domain constructs were localized in the nucleus and diffusely in the cytoplasm. The SARA FYVE domain construct localized to vesicular structures in the cytoplasm, which correspond to endosomes. Treatment with dimerizer greatly enhanced the localization of FYVE domain constructs to endosomes, with the exception of the FGD1 FYVE domain construct, which lacks the canonical tryptophan residue necessary for PtdIns3P recognition.
